New Delhi, April 9 Glenmark Pharmaceuticals announced on Thursday that it has received final approval from the US health regulator for its generic version of progesterone vaginal inserts used in fertility treatments.The approval from the US Food and Drug Administration (USFDA) is for 100 mg...
bioequivalence
drug approval
endometrin
fertility treatments
generic pharmaceuticals
glenmark pharmaceuticals
medical devices
north america
pharmaceutical sales
progesteronevaginalinserts
therapeutic equivalence
us food and drug administration (usfda)
us market
vaginalinserts
women's healthcare